BMRN vs CYN · P/E 40, rev $1.76B vs rev $249.0K
Biomarin Pharmaceutical Inc (BMRN) versus Cyngn Inc (CYN) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Cyngn Inc (CYN) is a software - application company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CYN revenue for 2026-06-30 was $249.0K. Net income was -$12.8M. CYN currently screens at market cap $23.8M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CYN currently screens at market cap $23.8M.
Not investment advice. Open the BMRN and CYN stock pages for the full models.
Not investment advice.